samedan logo
 
 
spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

T3: Trials, Tech and Transformation

T3_2018

30-31 May 2018
Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up. And this year, we're in Raleigh.

Explore:

• Paradigm Shifts in Clinical Trials: Partnerships and Collaboration, Digital Transformation, New Technology and Innovation, and The Changing Landscape

• Patients as Partners: Voice of the Patient, Recruitment and Engagement

• Clinical Research: Real-Time Data and Analytics

• Insights and Innovations from Immuno-oncology and Rare Disease

Book now to secure your place alongside leading clinical professionals on 30-31 May, ask your questions, and put yourself at the heart of the latest clinical discussions.

Download the agenda to see what we have lined up for you: https://goo.gl/cMq9qC

Visit the website to find out more: www.t3clinicalevent.com

 

phone 1 941-554-3500
email register@knect365.com
web goo.gl/VucvDb
email Raleigh Convention Center, NC
 
Print this page
Send to a friend
   
spacer
Industry Events

2019 PDA Annual Meeting

11-13 March 2019, Marriot Marquis San Diego, CA

Get the most current and comprehensive information on pharmaceutical processing, manufacturing, supply chain, and quality control. Benefit from plenary sessions, concurrent tracks, topic-specific Interest Group sessions, an exhibition, and networking opportunities.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>


News and Press Releases

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement